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Abstract
Artificial intelligence (AI) refers to the simulation of human intelligence in 
machines programmed to convert raw input data into decision-making actions, 
like humans. AI programs are designed to make decisions, often using deep 
learning and computer-guided programs that analyze and process raw data into 
clinical decision making for effective treatment. New techniques for predicting 
cancer at an early stage are needed as conventional methods have poor accuracy 
and are not applicable to personalized medicine. AI has the potential to use smart, 
intelligent computer systems for image interpretation and early diagnosis of 
cancer. AI has been changing almost all the areas of the medical field by 
integrating with new emerging technologies. AI has revolutionized the entire 
health care system through innovative digital diagnostics with greater precision 
and accuracy. AI is capable of detecting cancer at an early stage with accurate 
diagnosis and improved survival outcomes. AI is an innovative technology of the 
future that can be used for early prediction, diagnosis and treatment of cancer.
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Core Tip: Early detection of cancer potentially enhances the chances for successful 
treatment and patient survival outcome. Artificial intelligence (AI), a field of computer 
science, aims to develop algorithms or computer programs with advanced analytical or 
predictive capabilities. The development of highly accurate AI algorithms for the early 
recognition of the disease is crucial not only for the rapid identification and diagnosis of 
cancer patients, but also for the treatment. Many AI platforms are being developed and 
approved by the US Food and Drug Administration for use in some areas of cancer, such 
as identifying suspicious lesions in cancer and interpretation of magnetic resonance 
imaging or computed tomography. Similarly, the Big Data to Knowledge initiative was 
launched by National Institute of Health to support the research and development of tools 
to integrate big data and data science into biomedical research. AI-guided clinical care has 
the potential to play an essential role in the screening, diagnosis and treatment of cancer.
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Cancer is a major public health problem and remains the second leading cause of 
death in the United States[1,2]. Early detection of cancer potentially enhances the 
chances for successful treatment and patient survival outcomes[1-3]. Prediction of early 
cancer and treatment response is a crucial issue in personalized treatment for cancer 
patients[4]. Artificial intelligence (AI), a field of computer science, aims to develop 
algorithms or computer programs with advanced analytical or predictive capabilities 
(Figure 1)[1,3,5]. Integration of AI technology into early detection of cancer could 
improve precision diagnosis, improve the clinical decision-making process, and lead to 
revolutionize the future of diagnostics and treatment[5,6].
AI innovation has the potential to affect several parameters of cancer therapy[5,6]. 
These include prediction, screening, analysis and interpretation of huge data sets, 
decoding tumor-imaging data, drug discovery and drug validation in a clinical 
setting[6,7]. Screening of tumor targets in both healthy and high-risk populations offers 
the opportunity to detect cancer early and with an improved recovery chance for 
treatment and cure (Figure 2)[7-9]. Advances in AI with machine learning and deep 
learning are rapidly evolving, and will soon change the science of cancer screening 
and detection[8,10]. There is a need to train cutting-edge AI technologies to predict early 
cancer in patients[5]. Although AI applications are still limited, the potential role of AI 
for early detection of cancer is huge to extract information on diagnosis, prognosis, 
and therapy responsiveness[5,11,12].
AI IN EARLY DETECTION OF CANCER
The precision algorithms of AI can be used to improve precision medicine to target the 
right patient for the right therapy at the right time[5,12,13]. The scoring of proliferation 
marker Ki-67 is highly relevant for early-stage breast cancer diagnosis, classification, 
prognosis, and treatment[2,4,7]. Automated brain tumor segmentation methods are 
computational algorithms that yield tumor delineation and have become an important 
diagnostic tool in planning precision medicine[4,7,14]. Accurate identification and 
detection of lymph node metastasis are critical for planning treatments for colon 
cancer[2,4,15]. Given the complexities and heterogeneity within the cancer data, AI-based 
algorithms can be used for digitalized identification of histopathologic tumor 
specimens and image analysis (Figure 1)[4,10]. Gene mutation prediction and validation 
using raw input digitized histopathology give promising results for six different 
genetic mutations (STK11, EGFR, FAT1, SETBP1, KRAS, and TP53) in lung 
cancer[2,4,7,10]. Mutations in KRAS, tumor protein P53 and predictive accuracy of these 
markers can be used for early diagnosis of cancer[1,2,4]. Clinicians have utilized AI to 
establish an early signature (Programmed death-ligand 1), which could predict the 
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Figure 1  Artificial intelligence (vehicle with innovative technology), machine learning (the engine that drives artificial intelligence) deep 
learning (the wave comes to healthcare), and raw data (feeding materials of the artificial intelligence engine).
Figure 2  Applications of artificial intelligence in tumor detection, diagnosis and treatment.
effectiveness of cancer immunotherapy[1,13].
Data analytics capabilities of AI have made a leap forward in recent years to predict 
cancer at its starting point[5,16,17]. Screening algorithms for cancer targets and processing 
data via AI will allow increased early detection and intervention[5,13,18]. Conventional 
cancer detection and treatment methods are expensive, time-consuming and often 
result in poor treatment outcomes[1,5,19]. To tackle this issue, the development of 
machine learning techniques is central to discovering novel biomarkers for early 
diagnostics[1,2,19]. Precise and early cancer diagnosis is fundamental for clinical 
management of cancer[2]. AI can accelerate drug discovery, harness biomarkers to 
accurately match patients to clinical trials, and truly personalize cancer therapy using 
only a patient's own data[2,5,20]. These advances are indicators that practice-changing 
cancer therapy empowered by AI may be on the horizon.
AI IN CLINICAL DIAGNOSTICS
The development of highly accurate AI algorithms for the early recognition of the 
disease is crucial not only for the rapid identification and diagnosis of cancer patients, 
but also for the treatment[6,21]. AI can be helpful in clinical diagnostics to ensure 
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adequate patient care[6]. Useful screening tools to precisely diagnose cancer, such as 
mammography, radiology and image processing would improve the efficacy of 
clinical diagnostics[22]. The AI algorithms are already developed with large data sets 
that show improved diagnostics than clinicians[22]. AI-aided diagnostics for detecting 
cancer at heterogeneous and complex stage, showed effectiveness in various clinical 
datasets[22].
Many AI platforms are being developed and approved by the US Food and Drug 
Administration for use in some areas of cancer, such as for the identification of 
suspicious lesions in cancer and interpretation of magnetic resonance imaging or 
computed tomography[23,24]. There are several AI algorithms for the screening of cancer, 
for the identification of flagged areas in tumors, or treatment trends, and for the 
evaluation of big data sets[23]. For instance, there is an AI algorithm to visualize lung 
nodules in lung cancer patients and another AI algorithm to detect breast 
abnormalities[25-27].
AI AND NEW EMERGING TECHNOLOGIES
Cutting-edge technologies such as AI are diffusing throughout the health-care system 
and reshaping patient care[15,28]. The volume of available data has grown exponentially, 
which can be used for early diagnosis and clinical decision-making process[5,15,28]. The 
revolution of AI in biomedical science is crucial to develop the concept of precision 
medicine[7,15]. Concurrent with the development of the field of precision medicine is an 
even larger revolution in understanding the events of early detection of cancer using 
digital technology[5,7]. AI in cancer has focused on risk prediction in the hopes of using 
risk information to influence health behaviors and treatment outcomes[4,7,15]. 
Understanding the science of early perdition in cancer offers tools and insights to help 
how to translate AI information into effective treatment (Figure 2)[4,18]. To date, AI has 
been used in many examples of clinical medicine[12,14]. For example, a smartphone app 
called DiagnosUs developed by AI technology for analyzing and annotating medical 
images and videos based on tight linkages between cancer prediction and patient 
treatment response[12,14,28].
AI could fuel everything from drug development to innovative design to new, 
better therapies[3,5,28]. Advanced analysis of big data with AI can make predictive 
modeling of biological processes transform research into development, and increase 
the accuracy to choose the right medication and dosage for complex diseases[5,28]. For 
example, the Google-backed company DeepMind has built a device that can diagnose 
different diseases in real-time[11,28]. It can be used for quick scan, diagnosis, and can 
detect early conditions such as diabetic retinopathy, age-related degeneration and 
cancer[11,28]. Similarly, the Big Data to Knowledge initiative was launched by National 
Institute of Health to support the research and development of tools to integrate big 
data and data science into biomedical research[11,29].
AI-guided clinical care has the potential to play an important role in screening, 
diagnosis and treatment of cancer[5,28]. The integration of AI technology into cancer care 
could further improve the accuracy and speed of diagnosis for better health 
outcomes[7,11,29]. Scientists trained computer algorithms to analyze patient images of 
prostate, breast and brain tumors[1,5,7,29]. It can be used at clinics as a tool to help with 
diagnosis, clinical decision-making and for the prediction of patient outcomes[1,29]. AI 
can predict commonly mutated genes, identify biomarkers, interpret complex images, 
and diagnose solutions for challenging types of cancer (Figure 2)[2].
CONCLUSION
AI has improved diagnosis and treatment outcomes in cancer patients[15]. AI can 
recognize patterns that can easily be missed by clinicians[10,15]. Cancer is an aggressive 
disease with a low survival rate, and the treatment process is lengthy and very 
costly[10]. Furthermore, the lack of large publicly available data sets, concerns over 
interpretation, lack of well-annotated databases, reproducibility and validation-issues 
have been significant barriers for AI practice and algorithm development[7]. There is a 
need to establish a central platform for sharing standardized cancer datasets to drive 
AI innovation[7]. In the near future AI can be integrated into a multitude of innovative 
emerging mobile health interfaces, such as digital technologies, smartphone apps and 
wearable devices, to develop real-time trackers for digital biomarkers that can explain, 
influence, and predict clinical outcomes[10,15,28].
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